How Pierre Fabre enhances their antibody developability platform with Prometheus Panta

August 19, 2024

Developability assessment is essential for selecting the best monoclonal antibodies (mAbs) candidates for clinical development.

Dr. Elsa Wagner, a senior discovery scientist at Pierre Fabre Laboratories in France, focuses on putting together a comprehensive developability platform for monoclonal antibodies (mAbs) in immuno-oncology. To achieve this, Dr. Wagner needs precise methods to assess key stability parameters, such as thermal unfolding, particle sizing, and aggregation. Faced with large libraries of potential candidates, her priority is to obtain highly accurate and reproducible data for confident decision-making.

In this testimonial, read why she chose the Prometheus Panta instrument for simultaneous measurements of Dynamic Light Scattering (DLS), Differential Scanning Fluorimetry (nanoDSF), Static Light Scattering (SLS), and backreflection.

You’ll learn about:

How Pierre Fabre Laboratories approaches developability assessment for mAbs candidates

The criteria that guided her decision for the Prometheus Panta as a solution for her developability platform

The benefits of combining simultaneous thermal and colloidal stability measurements for confident ranking of mAbs candidates

For more information about Prometheus Panta for biologics developability assessment watch this video.

Optimization of membrane proteins for cryo-EM: Screening of copolymer nanodiscs with Prometheus Panta

Membrane proteins present challenges for structural analysis by cryo-EM; Screening of synthetic copolymers ...

Up next

Four integrated technologies for biologics developability assessment

The decisions you make about your biologics candidates early in the pipeline ultimately affect their succes...

Ready to tackle your challenging stability characterizations?

Discover tools

Return to education center

How Pierre Fabre enhances their antibody developability platform with Prometheus Panta

Previous

Up next

See more related content

Membrane proteins present challenges for structural analysis by cryo-EM; Screening of synthetic copolymers with nanoDSF and DLS on Prometheus Panta help select the best solubilization conditions.

The decisions you make about your biologics candidates early in the pipeline ultimately affect their success as therapeutics. Combine sizing and stability information to develop successful biologics

Your protein stability characterization projects require tools that provide high-precision, high-quality data to support your selection process. Watch this 10 min walkthrough of Prometheus Panta.

Get developability profiles for monoclonal antibodies with stability data from Prometheus Panta to inform on rational design and selection of therapeutic constructs that will succeed in the clinic.

Join this conversation to gain insight into how the Analytical and Formulation Sciences team at Thermo Fisher Scientific approaches stability assessment of biologic, and how the Prometheus Panta helps

The work of pre-formulations scientists is critical to de-risk the entire development process for biologics. Read on to learn more about what to consider about your buffer components for...

Learn how to identify optimal buffer conditions during pre-formulation, with multi-parameter stability characterization from Prometheus Panta, a tool to collect thermal and colloidal data while saving

For pre-formulations researchers looking to find buffers that stabilize early development biologic products, buffer optimization goes beyond the pH and salt concentration of the solution....

Developability assessment is a critical part of the evaluation and selection of candidates for further optimization and development for biologics researchers. This work entails collecting, ranking, an

Choosing the right stability characterization tool for your biologics research is a big commitment. You’re going to be screening and optimizing lots of candidates, and you’ll need data on thermal stab

In this video, Nathan Wallace, Application Specialist at NanoTemper, addresses common questions about experimental design for developability profiling and the operation of Prometheus Panta.

For antibody-drug conjugate (ADC) development, scientists rely on stability experiments using fluorescence and light scattering techniques to predict the conjugated molecule's behavior.

Learn how it’s possible to use the Prometheus Panta to extrapolate how your low concentration sample will behave once it’s scaled up and at higher concentrations used for clinical administration.

Characterize the developability of antibody-drug conjugates: Multi-parameter stability assessment with Prometheus Panta makes it possible to examine multiple aspects of ADC stability in parallel.

Read this nanoDSF guide to learn how nano-Differential Scanning Fluorimetry (nanoDSF) uses your protein’s intrinsic fluorescence to determine its melting temperature, Tm and onset of melting, Ton.

Thermal stability screening is a common approach used to study the developability of a wide range of protein-based therapeutics. Among the different technologies available to perform thermal stability

Learn about Differential Scanning Calorimetry (DSC), Circular Dichroism (CD), Extrinsic Differential Scanning Fluorimetry, and nano-Differential Scanning Fluorimetry for thermal stability of proteins

Learn about four methods for thermal stability measurements: DSC, CD, DSF and nanoDSF. You'll review their pros and cons, what they data tell you and why it's important for biologics developability.

During early development of biologics, there are many attributes scientists evaluate for developability. Measure them with biophysical characterization using nanoDSF, DLS, backreflection, and SLS.